Henry Yang

16.5k citations
168 papers · 8.7k indexed · 1 hit paper · h-index 48

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • RNA modifications and cancer
    • Epigenetics and DNA Methylation
    • RNA Research and Splicing
    • Pluripotent Stem Cells Research
    • CRISPR and Genetic Engineering

Papers in

    • RNA Research and Splicing 32
    • RNA modifications and cancer 30
    • Epigenetics and DNA Methylation 29
    • Pluripotent Stem Cells Research 22
    • CRISPR and Genetic Engineering 20
    • Cancer-related gene regulation 17
    • RNA regulation and disease 14
    • Genomics and Chromatin Dynamics 13

Henry Yang

165 papers receiving 8.6k citations

Hit Papers

LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade 2018 · 462 citations
4622018202620202023100200300400

Peers

Henry Yang
Comparison fields: 5 of 150
  • Cancer Research 2.1k
  • Molecular Biology 5.9k
  • Immunology 1.6k
  • Hematology 663
  • Oncology 1.5k
Replace Andréas Bikfalvi with:
Andréas Bikfalvi France
Shoumo Bhattacharya United Kingdom
Keiji Miyazawa Japan
James DeGregori United States
Beat W. Schäfer Switzerland
Noboru Motoyama Japan
Gustavo Leone United States
Jason D. Weber United States
Zhengping Zhuang United States
Marc Vooijs Netherlands
Henry Yang relative to Andréas Bikfalvi France Andréas Bikfalvi's profile →
Citations per field
00.5×
Andréas Bikfalvi · 1×
Citations per year

Countries citing papers authored by Henry Yang

Since Specialization
Citations

This map shows the geographic impact of Henry Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Yang more than expected).

Fields of papers citing papers by Henry Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Yang. The network helps show where Henry Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Henry Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henry Yang Line = papers co-authored together Henry Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20241
3 202312
4 202148
5 20219
6 20215
7 202113
8 20213
9 202011
10 202021
11 202078
12 201931
13 201913
14 201920
15 201844
16 201821
17 201551
18 2015173
19 201214
20 2010392

About Henry Yang

Henry Yang is a scholar working on Cancer Research, Molecular Biology, Hematology, Oncology and Immunology, having authored 168 papers that have together received 8.7k indexed citations. Recurring topics across this work include RNA Research and Splicing (32 papers), RNA modifications and cancer (30 papers), Epigenetics and DNA Methylation (29 papers), Pluripotent Stem Cells Research (22 papers), CRISPR and Genetic Engineering (20 papers), Cancer-related gene regulation (17 papers), RNA regulation and disease (14 papers) and Genomics and Chromatin Dynamics (13 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (5.9k citations), Immunology (1.6k citations), Hematology (663 citations) and Oncology (1.5k citations). Henry Yang has collaborated with scholars based in Singapore, United States and China. Frequent co-authors include Bing Lim, Kian Leong Lee, Lorenz Poellinger, Urban Lendahl, H. Phillip Koeffler, Wai Leong Tam, Daniel G. Tenen, Huck‐Hui Ng, Ian McNiece and Meng Ling Choong. Their work appears in journals such as Nature Communications, Cancer Research, Blood, Nucleic Acids Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026